Melatonin and Ramelteon Combination Therapy

Introduction to Combination Therapy

• The American Academy of Sleep Medicine and the American College of Physicians suggest that ramelteon and melatonin work through the same melatonin receptor mechanism, making combination therapy theoretically redundant rather than synergistic 1, 2, 3

Efficacy of Ramelteon

• The American Academy of Sleep Medicine suggests ramelteon 8 mg for sleep onset insomnia only, with weak evidence showing marginal reductions in sleep latency (approximately 7-13 minutes) 3, 4
• The American College of Physicians found low-strength evidence that ramelteon did not significantly reduce sleep variables compared to placebo in their meta-analysis, though one study in older adults showed 10-minute improvement in sleep onset latency 1, 2

Efficacy of Melatonin

• Evidence for melatonin efficacy is insufficient, with one RCT (n=791) showing small effect sizes that were not clinically meaningful 1, 2
• Melatonin manufacturing in the United States is not FDA-regulated, raising concerns about quality and consistency that have prevented many hospitals from formulary addition 5, 6

Clinical Implications

• If ramelteon alone is ineffective, the American College of Physicians recommends switching to alternative agents with stronger evidence (suvorexant, eszopiclone, low-dose doxepin) rather than adding melatonin 1, 7, 8
• The American Academy of Sleep Medicine recommends suvorexant 15 mg as first-line medication for elderly patients with insomnia due to superior efficacy (55% response rate vs 42% placebo) and moderate-strength evidence 8

Safety and Efficacy Considerations

• No safety data exist for melatonin-ramelteon combination, though both have relatively benign side effect profiles individually 1, 6
• Ramelteon has no abuse potential and is not a controlled substance, making it preferable to benzodiazepines, but this does not justify combination with melatonin 4